- Report
- November 2023
- 160 Pages
Global
From €3182EUR$3,599USD£2,747GBP
- Report
- April 2023
- 147 Pages
Global
From €4376EUR$4,949USD£3,778GBP
- Report
- January 2021
- 201 Pages
Global
From €3183EUR$3,600USD£2,748GBP
- Report
- August 2024
- 180 Pages
Asia Pacific
From €3421EUR$3,869USD£2,953GBP
- Report
- December 2023
- 160 Pages
United States
From €2466EUR$2,789USD£2,129GBP
- Report
- May 2023
- 147 Pages
Global
From €4376EUR$4,949USD£3,778GBP
- Report
- April 2023
- 147 Pages
Global
From €4376EUR$4,949USD£3,778GBP
- Report
- October 2023
- 180 Pages
Global
From €1105EUR$1,250USD£954GBP
€2210EUR$2,500USD£1,908GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €663EUR$750USD£572GBP
€1326EUR$1,500USD£1,145GBP
- Report
- October 2023
- 80 Pages
India
From €663EUR$750USD£572GBP
€1326EUR$1,500USD£1,145GBP
- Report
- October 2023
- 80 Pages
Germany
From €663EUR$750USD£572GBP
€1326EUR$1,500USD£1,145GBP
- Report
- October 2023
- 80 Pages
France
From €663EUR$750USD£572GBP
€1326EUR$1,500USD£1,145GBP
- Report
- October 2023
- 80 Pages
United States
From €663EUR$750USD£572GBP
€1326EUR$1,500USD£1,145GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €663EUR$750USD£572GBP
€1326EUR$1,500USD£1,145GBP
From €663EUR$750USD£572GBP
€1326EUR$1,500USD£1,145GBP
- Report
- October 2023
- 80 Pages
South Korea
From €663EUR$750USD£572GBP
€1326EUR$1,500USD£1,145GBP
- Report
- March 2024
- 249 Pages
Global
€4416EUR$4,995USD£3,813GBP
- Report
- September 2023
- 114 Pages
Global
From €2608EUR$2,950USD£2,252GBP
- Report
- September 2023
- 87 Pages
Middle East, Africa
From €2608EUR$2,950USD£2,252GBP
- Report
- September 2023
- 89 Pages
From €2608EUR$2,950USD£2,252GBP

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis.
Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases.
Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more